- Home
- WTTR vs BBOT Comparison
WTTR vs BBOT Comparison
Compare WTTR & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTTR | BBOT |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | WTTR | BBOT |
|---|---|---|
| Price | $11.16 | $13.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $15.00 | ★ $23.80 |
| AVG Volume (30 Days) | ★ 753.0K | 259.9K |
| Earning Date | 02-17-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.49% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $1,409,889,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $58.10 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.20 | $8.50 |
| 52 Week High | $14.66 | $14.87 |
Technical Indicators
Market Signals| Indicator | WTTR | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 53.85 | N/A |
| Support Level | $10.75 | N/A |
| Resistance Level | $11.72 | N/A |
| Average True Range (ATR) | 0.36 | 0.00 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 51.54 | 0.00 |
Price Performance
Historical ComparisonAbout WTTR Select Water Solutions Inc.
Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure and Chemical Technologies. It generates the majority of its revenue from Water Services segment.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.